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Abstract
Inverse fusion PCR cloning (IFPC) is an easy, PCR based three-step cloning method that allows the seamless and directional
insertion of PCR products into virtually all plasmids, this with a free choice of the insertion site. The PCR-derived inserts
contain a vector-complementary 59-end that allows a fusion with the vector by an overlap extension PCR, and the resulting
amplified insert-vector fusions are then circularized by ligation prior transformation. A minimal amount of starting material
is needed and experimental steps are reduced. Untreated circular plasmid, or alternatively bacteria containing the plasmid,
can be used as templates for the insertion, and clean-up of the insert fragment is not urgently required. The whole cloning
procedure can be performed within a minimal hands-on time and results in the generation of hundreds to ten-thousands of
positive colonies, with a minimal background.
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Introduction
Commercially available systems allowing the directional inser-
tion of PCR products into vectors such as the topoisomerase based
Champion system (Invitrogen) are easy to use but limited to the
vectors provided and to fixed cloning sites. Alternative methods for
insertion of PCR products, allowing a free choice of the insertion
site have been developed. These methods can be divided in two
groups, namely systems where additional sequences such as
restriction or recombination sites are present at the insertion-
boundaries after cloning [1–3] and seamless cloning methods
without additional sequences [4]. In a directional way, seamless
cloning of PCR products into linearized vectors can be performed
by applying type-II restriction enzymes [5]. Despite their
differences in implementation, other seamless cloning methods
start with a linearized vector and a PCR amplified insert
containing sequences that are homologous to the vector on both
ends. With this starting material seamless cloning can be
performed by in vivo recombination using special E. coli strains
[6], by in vitro recombination using E. coli extracts [7] or by
annealing, if long single stranded cohesive ends are present in the
vector and insert sequences. These cohesive ends can remain as a
result of incomplete PCR after vector and insert amplification
[8,9], they can be generated in a PCR setup [10] or prepared
enzymatically [8,11]. The commercially available systems In-
Fusion (Clontech), Geneart (Invitrogen) or CloneEZ (GenScript)
are based on enzymatically prepared cohesive ends. Another
possibility to combine vector and insert is to fuse both in a non-
exponential PCR setup, which can be performed with linearized
[12] or circular vector [13–15]. Most of the alluded methods result
in insert-vector fragments containing gaps or nicks that are filled
and ligated by the cellular DNA repair machinery after
transformation. Commonly, the insert is amplified by PCR and
with the exception of the last PCR based setups, the vector is
prepared by restriction digestion, or alternatively by PCR in case
no adequate restriction sites are present. Depending on the cloning
method, more than 200 ng linear vector DNA per reaction is
necessary, and quantitative preparation of the high molecular
vectors by PCR is, however, not very effective. Additionally,
plasmids might not be efficiently digested, which may lead to false
positive background due to uncut vector. Next to the large
amounts of insert and vector DNA, some of the methods require
additional complex or time consuming working steps, many and/
or long primers, or they have a low yield in colony numbers. As a
consequence, seamless directional cloning could be optimized by
(i) reducing the number of steps required for the preparation of
insert and vector, (ii) reducing the amount of required starting
material, and (iii) increasing the yield of positive colonies.
Inverse fusion PCR cloning (IFPC) as it is described here fulfils
all three criteria. IFPC requires no preparative work to be done on
the vector DNA, and only one facultative clean up step for the
insert DNA. Moreover, very low amounts of starting material are
necessary, and high counts of positive colonies are achieved, with a
minimal background. The principle of IFPC is schematically
drawn in Figure 1. IFPC is a combination of two established PCR
methods, namely a fusion- or overlap extension-PCR [16] which
allows the joining of two PCR products, and an inverse-PCR
[17,18], which allows e.g. the insertion of point mutations into
plasmids or the deletion of plasmid sequences. A combination of
both PCR methods, named here inverse fusion PCR, is used for
directional seamless insertion of PCR products containing a
vector-complementary 59-end into plasmids, with a free choice of
the insertion site. An important feature of IFPC is the exponential
amplification of the fused vector-insert fragments during the
inverse fusion PCR step. Thus minimal amounts of starting
material (.0.5 ng for a 4 kb plasmid and,10 ng for a 1 kb insert)
can be used to produce high yields of colonies. Only three primers
are needed to perform IFPC. The insert is amplified with the
forward primer A and the reverse primer B, and primer A contains
a 59-sequence homologous to the desired vector insertion site. For
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the inverse fusion PCR step, insert, vector, primer B and the
vector specific primer C are used. During inverse fusion PCR two
things happen. First the reverse insert strand anneals to the
complementary vector sequence with its vector homologous 39-
end like a primer and is then elongated by primer extension, thus
forming the fused insert-vector template. In a second step the
linear insert-vector fusion is exponentially amplified via primers B
and C. For the inverse fusion PCR a high fidelity DNA
polymerase with proofreading activity should be used to minimize
PCR artefacts and to produce blunt ended fragments. These can
be circularized by ligation. For the ligation at minimum one of the
59-ends of the insert-vector fragment has to be phosphorylated.
This can be achieved by using either a 59-phosphorylated primer B
or primer C in the inverse fusion PCR step or by phosphorylating
the final insert-vector fragments with T4-polynucleotide kinase
(pnk). When a phosphorylated primer is used, the final circularized
fragments contain a nick at the 59-end of the non phosphorylated
primer that will be closed by the cellular DNA repair machinery
after transformation. The hands-on time for performing IFPC is
very low, since bacteria containing the vector and diluted insert
PCR can be used as templates for the inverse fusion PCR, which is
then just mixed with ligation buffer and ligase prior transforma-
tion. If non phosphorylated primers were used, additionally pnk
has to be added to the ligation mix.
Results
Experimental setup (Figure 2 A)
In order to characterize IFPC as a method for functional
expression of proteins in E. coli, the replacement of the ampicillin
resistance gene of the vector pBAD by a kanamycin resistance
gene was chosen, thus allowing a simple screen for functional
insertions by counting kanamycin resistant colonies versus
ampicillin resistant background colonies. Clean-up or enzymatic
treatment steps were reduced by using circular vector as template
for the inverse fusion PCR and a T4-ligation system working with
crude PCR reactions. Since some settings resulted in very high
counts of positive clones, the number of colonies is given as a value
corresponding to 1 ml of the initial inverse fusion PCR and not as
the commonly used clone forming units (cfu) per mg of DNA. The
first PCR (amplification of insert) was performed under standard
conditions. In order to optimize the second or inverse fusion PCR
conditions, three main parameters were tested. These were (i) the
amount of circular template vector pBAD (1 pg to 50 ng), (ii) the
ratio of vector to insert (1: 0.1 up to 1: 1000), and (iii) the quality of
the insert (crude PCR, column-cleaned PCR, or the gel-eluted
insert). Moreover, E. coli containing the vector pBAD were used as
a template for the inverse fusion PCR. Finally the 59-phosphor-
ylation of the fusion PCR products by a T4-polynucleotide-kinase
was compared to the use of phosphorylated primers.
Evaluation of IFPC
A good range for the amount of vector to be used was between
12 and 20 pg per 1 ml of inverse fusion PCR, yielding between
10,700 and 24,000 colonies per ml fusion PCR. Employing lower
amounts resulted in reduced colony numbers (Table 1, Nu. 1–7),
and higher amounts (.100 pg ml21) yielded high numbers of
residual ampicillin resistant background colonies (data not shown).
The ideal vector to insert ratio was 1:100. Higher ratios did not
result in more colonies (data not shown) and lower ratios again
resulted in fewer colonies (Table 1, Nu. 7–10). The quality, or
purity, of the insert DNA had a clear influence on the numbers of
positive colonies. Gel-purified insert DNA gave the highest
number of colonies, namely 24,000, while for column-cleaned
insert DNA, the yield was reduced to 50%, and with diluted crude
PCR products, still 6600 cfu per ml inverse fusion PCR reaction
were obtained, corresponding to a 75% reduction as compared to
gel-purified insert DNA (Table 1, Nu. 7 as compared to 11 and
12). All these inverse fusion PCRs were performed with a long
annealing step starting from 65uC followed by slowly decreasing
the temperature at 0.1uC s21 down to 58uC. To speed up the
inverse fusion PCR, the annealing step was shortened to 30 s at
58uC, which resulted in a decrease of colony numbers of only 20%
(Table 1, Nu. 7 as compared to 13). Since with crude product of
the insert PCR the number of kanamycin resistant colonies was
still around 6,600 per ml of the inverse fusion PCR reaction, it was
tempting to test whether the whole procedure would succeed
without any cleanup step. Thus, the inverse fusion PCR was
performed with an E. coli colony harbouring pBAD, suspended in
H2O and mixed with diluted crude insert PCR. The amount of
kanamycin resistant colonies was clearly reduced as compared to
the use of purified plasmid and insert, but depending on the
dilution, up to 830 colonies could still be detected (Table 1, Nu.
14–18 as compared to 11).
Subsequent investigations were done to see whether phosphor-
ylation of primer B versus primer C influences the yield of positive
colonies, and whether there is an effect in case the inverse fusion
PCR product is phosphorylated with polynucleotide kinase (T4-
pnk) during a reaction employing non-phosphorylated primers.
With a phosphorylated primer C, the number of positive colonies
was 7 times higher than with a phosphorylated primer B (Table 1,
Nu. 7 as compared to 19). Compared to a control with a
phosphorylated primer C nearly 15 times less colonies were
obtained when a non-phosphorylated primer C was used and the
inverse fusion PCR products were treated with T4-polynucleotid
kinase in one step in the ligation mix (Table 1, Nu. 7 as compared
to 20–21).
Finally, two different ligation systems working in the presence of
PCR reaction buffer were tested, namely the quick ligation system
from NEB and the rapid ligation system from Promega. Both
systems resulted in almost similar counts of colonies. In contrast,
isopropanol-precipitation of the fused PCR products followed by a
standard T4-ligation resulted in less than 10% colonies (data not
shown). Since the ligation is normally carried out at room
temperature and the pnk-phosphorylation is done at 37uC, both
setups were also incubated at 37uC resulting in very low counts of
colonies (data not shown).
Error frequency of IFPC (Figure 2B)
The experiments described above were dealing with the number
of positive, thus functional, fusions selected by the exchange of the
ampicillin into a kanamycin resistance. In the next step, the
numbers of negative, non-functional fusions were determined.
With this setup the insertion and the expected error rate of non
selectable sequences can be mimicked. For this, the kanamycin
resistance gene of the vector pCR2.1 (both, ampR and kanaR) was
exchanged by the in-frame insertion of a spectinomycin resistance
gene to detect non-functional fusions. The typical read-outs of this
experiment were ampicillin and spectinomycin - but not
kanamycin - resistance in the case of a functional fusion, or only
ampicillin resistance in the case of a non-functional fusion due to
deletion of the kanamycin resistance gene by insertion of a non-
functional spectinomycin resistance gene. From 192 randomly
picked ampicillin resistant colonies 172 (,90%) were ampicillin
and spectinomycin resistant, representing functional fusion events.
96 of these functional colonies were tested by a specific colony
PCR resulting in an identical banding pattern for all colonies (data
not shown). Furthermore, plasmids of 10 of these colonies were
Inverse Fusion PCR Cloning
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sequenced and no alterations were detected on the 59- and 39-
boundaries or inside the spectinomycin sequence. Seven of the
ampicillin resistant colonies (,3.5%) still contained a functional
kanamycin resistance gene, indicative for background. 13 of the
ampicillin resistant colonies (,6.5%) were susceptible to specti-
nomycin and to kanamycin and thus represented non-functional
fusion events. These colonies were analyzed by sequencing to
detect the reason for the failure of functional fusion. One colony
contained no spectinomycin sequence but a mutated non-
functional kanamycin resistance gene. Six colonies were found to
be fusions of the template vector pCR2.1 and different bacterial
DNA sequences and six colonies exhibited truncated spectinomy-
cin sequences lacking parts of their C-terminus due to mismatched
primer B3.
Optimization of IFPC
With similar settings, the pCR2.1-spectinomycin experiment
resulted in 1430 positive colonies, representing only ,5% of the
yield obtained in the pBAD-kanamycin experiment (data not
shown). In rare cases similar reduced clone counts were observed
for single inserts when different inserts were cloned using the same
vector insertion site (data not shown). Additionally, less than 100
positive colonies were observed when the ampicillin/kanamycin
resistance exchange approach was performed with the vector
pBAD-TOPO/lacZ/V5-His. Since the only difference between
Figure 1. Schematic outline of inverse fusion PCR cloning (IFPC). (Primer design) 3 primers are required for IFPC. For the amplification of
the insert, the forward primer A and the reverse primer B are used. Primer B is an insert-specific standard primer while the 59-end of primer A is
comprised of a sequence homologous to the desired insertion site of the vector (black) and the 39-end is specific for the insert (white). The annealing
site for the vector primer C has to be chosen downstream of the insertion site, and must not overlap with the insertion site. The annealing Tm of
primer B, primer C, the vector homologous part of primer A as well as the insert specific part of primer A should all be around 58uC. Depending on
how IFPC will be performed, primer B or primer C can be 59-phosphorylated (see below). The sequence between the insertion site and primer C will
be deleted after IFPC. (Inverse fusion PCR cloning) (1.) The insert (white) is amplified via primers A and B and should be gel-eluted when
unspecific PCR products or smears appear. (2.) For the inverse fusion PCR, a mix containing insert-PCR product, circular plasmid template, primer B
and phosphorylated primer C is prepared. In the first rounds of PCR, forward strands of vector and reverse strands of insert are enriched by primer-
extension of primers B and C in a linear way (2.1). Then, the insert reverse strands anneal with their vector homologous 39-end to the complementary
sequence (black) of the linear plasmid forward strands (2.2.) and the inserts are elongated by overlap extension (2.3.), thus forming the fused insert-
plasmid template lacking the original sequence of the template plasmid between the insertion site and primer C (2.4.). The second strand of the
template is generated by primer extension of primer C, finalizing the double-stranded template (2.5.), which is now exponentially amplified via primer
B and C (2.6.). The linear insert-plasmid fusions are now circularized by T4-ligation (3.). As an alternative to phosphorylated primer C, a
phosphorylated primer B can be used, or the phosphorylation can be incorporated by T4-polynucleotide-kinase treatment during the ligation step.
Finally the ligated insert-vector fusions are transformed into competent E.coli (4.), where the bacterial DNA repair machinery will close the nick of the
second strand. A working protocol is shown in material and methods.
doi:10.1371/journal.pone.0035407.g001
Inverse Fusion PCR Cloning
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pBAD used for the optimization experiments and pBAD-TOPO/
lacZ/V5-His is the presence of the full lacZ gene in the latter one, it
was mentioned that the low colony yield was a result of poor
template amplification. To address this question, two experimental
setups were performed with the vector pBAD-TOPO/lacZ/V5-
His. First the cycle number of the inverse fusion PCR was
increased and as a result 30 cycles yielded in 920 colonies and 35
cycles in 1560 colonies. Because primer C1 has a very low melting
temperature of,50uC, a second IFPC was performed with primer
C1-b (Tm 62uC), yielding 12,000 colonies after 25 cycles, 19,600
colonies at 30 cycles, and 15,700 colonies at 35 cycles. The control
setup using pBAD as template and C1-b as a primer resulted in
270,000 colonies per ml of inverse fusion PCR. At 25 cycles the
yield of colonies was approximately 5% compared to the control.
60% more colonies were obtained by adding 5 cycles to the inverse
fusion PCR. The final inverse fusion PCR products (10 ml per
lane) are shown in Figure 2 C. It should be noticed at this point,
that these PCR products were prepared with primer C1-b and that
for almost all experiments described before (pBAD/optimization,
pCR2.1/spectinomycin) only very light or even no bands were
visible in the gel (data not shown), but nevertheless resulted in high
colony counts.
Discussion
IFPC is a fast cloning method, requires low amounts of starting
material, few experimental steps, and results in a high yield of
positive colonies. To perform an IFPC, a bacterial colony
containing the template vector can be suspended in a convenient
amount of water, and an inverse fusion PCR reaction is performed
Figure 2. Experimental setup for the exchange of antibiotic resistances by inverse fusion PCR cloning. (A) The ampicillin resistance
gene of the vector pBAD was exchanged by a kanamycin resistance gene. Via selection on ampicillin plates the residual background was detected,
and through kanamycin selection the functional fusions were identified. This setup positively selected functional fusions and was used to optimize
the system. (B) The kanamycin gene of the vector pCR2.1 was exchanged by an in-frame insertion of a spectinomycin gene (aadA). (1) In a first round,
the ampicillin resistant colonies were selected, containing the vector with or without insertion. (2) In a second round, 192 of the ampicillin resistant
colonies were used. Background containing the original vector was selected in LB media by addition of kanamycin and functional spectinomycin
fusions by addition of spectinomycin. (3) 10 spectinomycin resistant clones were sequenced for sequence confirmation and all clones sensitive to
kanamycin and spectinomycin were sequenced to identify the reason of IFPC failure. With this setup the insertion of non selectable sequences could
be mimicked, because background (kanR), successful insertions (specR) and failed fusions (kanS/specS) were detected. By calculating the relationship
between successful insertions and failed fusions, the failure frequency of IFPC was specified to be 6.5% in this experiment. (C) Results of an inverse
fusion PCR to change the ampicillin into a kanamycin resistance in the vectors pBAD (lanes 1–7) or pBAD-TOPO/lacZ/V5-His (lanes 8–10). The molarity
of vector and insert templates in lanes 1–7 correspond to the amounts shown in Table 1 (Nu. 1–7) and in lanes 8–10 to the amount shown in Table 1
(Nu. 7), but 25 cycles (lane 8), 30 cycles (lane 9) and 35 cycles (lane 10), respectively, were performed in the inverse fusion PCR step. The PCR was run
using primer B1 and primer C1-b. 10 ml of each PCR were loaded on the gel and resulted after ligation and transformation in 260.000 cfu (lane 7),
12.000 cfu (lane 8), 19.600 cfu (lane 9) and 15.700 cfu (lane 10) per ml of inverse fusion PCR. M: Bench Top1 kb ladder (Promega).
doi:10.1371/journal.pone.0035407.g002
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with the desired insert. This procedure already gives high yields of
positive colonies but by using a purified vector template and a gel-
eluted insert the yield can be increased by two orders of
magnitude. IFPC tolerates a wide range of setup possibilities and
is therefore successful even under non-ideal conditions, where
unfavourable vector to insert ratios or very low amounts of
template are found.
In both described setups the vector homologous overlap of
primer A was calculated with an annealing Tm of around 58uC,
but overlaps with lower annealing Tms did also provide good
results (data not shown). If the insert PCR results as a clear band
without additional products, it can be used as a diluted PCR, but if
smears or additional products are present, a gel elution is
recommended. A high-fidelity DNA polymerase with proofreading
activity should be used, since blunt ends are mandatory for the
final ligation and enzymes such as Phusion (FinnZymes or NEB)
show a very low failure frequency. The 59-phosphorylation
necessary for the ligation can be incorporated by 59-phosphory-
lated primers B or C resulting in high number of colonies, or by
phosphorylation with T4-polynucleotide-kinase resulting in a
lower yield of colonies most likely due to the presence of
ammonium sulphate in the PCR buffer and a suboptimal reaction
temperature of 25uC. The amount of inverse fusion PCR used for
the combined phosphorylation/ligation step still has place for
optimization, but it results in the described settings in sufficient
colony counts, thus saving time by avoiding additional cleanup
steps or other experimental treatments. Combined phosphoryla-
tion/ligation may be the method of choice in the case of many
IFPCs on different insertion sites or template vectors or in the case
phosphorylated primers are too expensive. An important factor for
the high yield of colonies as described here is the usage of highly
competent E.coli. Therefore, a meaningful comparison between
different cloning methods as described in the introduction is not
really possible. Normally nobody requires 20,000 identical clones,
but highly competent E. coli could be helpful when IFPC is
performed under suboptimal conditions, e.g. when bacteria
containing the template vector are used as template, when T4-
pnk is employed for phosphorylation, or when templates are
poorly amplified. The fact that IFPC allows template flexibility
and requires only minimal amount of starting material renders
IFPC a promising cloning strategy for low-copy vectors.
On the other hand, limitations regarding PCR should be kept in
mind when IFPC is planned. Since IFPC results in an exponential
amplification of the template, it exhibits all advantages and
Table 1. Conditions and cloning rates for kanamycin insertion into pBAD by IFPCa.
N6.
Vector (V) and Insert (I) per 1 ml of
inverse fusion PCR setup
Molarity
V: I (pM) Ratio V: I
KanR cfu ml21
fusion PCR
AmpR cfu ml21
fusion PCR variable conditionsb
1 0.2 pg V+4 pg I 0.08: 8.0 1:100 - -
2 2 pg V+40 pg I 0.8: 80 1:100 12 -
3 4 pg V+80 pg I 1.6: 160 1:100 600 -
4 8 pg V+160 pg I 3.2: 320 1:100 1,100 2
5 12 pg V+240 pg I 4.8: 480 1:100 10,700 7
6 16 pg V+320 pg I 6.4: 640 1:100 23,000 4
7 20 pg V+400 pg I 8.0: 800 1:100 24,000 1
8 20 pg V+200 pg I 8.0: 400 1:50 6,900 4
9 20 pg V+40 pg I 8.0: 80 1:10 200 3
10 20 pg V+4 pg I 8.0: 8.0 1:1 20 4
11 20 pg V+400 pg I 8.0: 800 1:100 6,600 4 insert: diluted crude PCR
12 20 pg V+400 pg I 8.0: 800 1:100 11,800 8 insert: PCR column cleanup
13 20 pg V+400 pg I 8.0: 800 1:100 19,500 9 annealing: 30 s – 58uC
14 1 colonyc in 50 ml H2O+400 pg I n.d.: 800 - - 13
15 1 colonyc in 500 ml H2O+400 pg I n.d.: 800 - 420 14
16 1 colonyc in 5 ml H2O+400 pg I n.d.: 800 - 830 6
17 1 colonyc in 50 ml H2O+400 pg I n.d.: 800 - 60 -
18 1 colonyc in 500 ml H2O+400 pg I n.d.: 800 - 19 -
19 20 pg V+400 pg I 8.0: 800 1:100 3,400 - primers B26C2
20 20 pg V+400 pg I 8.0: 800 1:100 1,540d 3 primers B16C2, T4-pnk
21 20 pg V+400 pg I 8.0: 800 1:100 1,870 (9,350)d 1 primers B16C2, T4-pnk, 0.2 ml
inverse fusion PCR
22 4 ng I -: 8,000 - - control: insert alone
23 20 pg V 8.0: - - 39 control: vector alone
a)For comparability all data shown was generated in one parallel setup.
b)The standard procedure and PCR conditions are described in the material and methods part. If not other mentioned, gel-eluted insert and plasmid derived from a
mini-prep were used as templates. Normally only a very light or even no band is visible on an agarose gel when 10 ml of the inverse fusion PCR was loaded.
c)Instead of plasmid an E. coli colony containing pBAD was used. pBAD is a high copy plasmid. Low copy plasmids will need lower dilutions for optimal IFPC
performance.
d)Since the (NH4)SO4 present in the PCR buffer inhibits phosphorylation by T4-pnk, one experiment was performed with 2 ml fusion PCR while the other one was
prepared with 0.2 ml. 1,870 colonies were counted per 0.2 ml of fusion PCR, for comparison 9,350 colonies are the calculated colonies per ml of fusion PCR.
doi:10.1371/journal.pone.0035407.t001
Inverse Fusion PCR Cloning
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disadvantages of conventional PCRs. The insert and the vector
have to be amplifiable and if the efficiency of PCR is low, resulting
in small counts of colonies, 5 or more PCR cycles should be added
to the inverse fusion PCR program, while introduction of more
template DNA will result in higher numbers of background
colonies. One example for poor template amplification resulting in
reduced colony yield is the lacZ sequence present as lacZa fragment
in many cloning vectors such as pCR2.1 or as full lacZ in the
vector pBAD-TOPO/lacZ/V5-His. The low yield of colonies
could be increased successfully after adding more cycles and this
showed that for some IFPCs optimization of the inverse fusion
PCR is necessary. Due to primer mismatching, repeated
sequences, or GC-rich domains, the inverse fusion PCR can fail,
thus resulting in low numbers of positive colonies and/or a high
background of false positive clones. As recommended for the used
Phusion DNA polymerase, the annealing temperature can be
raised to allow for a more specific primer binding. In any case the
insertion sites and primers should be chosen with care, and for
IFPC on new vectors a pilot experiment with different primer
combinations is recommended. Moreover, multiple or serial
insertions by IFPC could be prone to PCR artefacts, since for
each insertion, the vector undergoes 25 and the insert 50 PCR
cycles. The estimated percentage of PCR products having an error
can be calculated for Phusion polymerase (http://www.finnzymes.
fi/pcr/fidelity_calc.php) and ranges on 50 cycles between 2.2% for
a 1 kb insert and 6.6% for a 3 kb insert and on 25 cycles for a 5 kb
vector at 5.5%. Therefore, especially for smaller inserts the risk of
PCR derived artefacts is negligible, but if the plasmid backbone
contains functional elements, a confirmation by sequencing might
be necessary. At last, IFPC may not be suitable for the cloning of
cDNA libraries since the inverse fusion PCR step exponentially
amplifies some initial vector/insert fusion events and may
additionally select inserts as a function of their sizes and GC
contents; thus, the resulting libraries will be biased. Therefore,
IFPC is best suited for the cloning of single sequences. The
assemblage of multiple inserts containing homologous overhangs
as shown for CPEC [12] should be possible by IFPC but was not
tested yet.
To mimic a standard cloning with a non selectable insert the
failure frequency of IFPC was analyzed employing a column-
cleaned PCR product and only 6.5% of the colonies contained a
non functional insertion. Half of the failure events could be
decreased by employing gel-eluted insert DNA, because fusions
between the template vector and genomic bacterial DNA were
detected. Interestingly, the other half of the failed fusions
contained C-terminal truncated sequences and no mismatching
events on the insertion boundaries, showing that the overlap
extension part of the inverse fusion PCR worked perfect in this
setup.
The number of background colonies containing the template
vector without insert is constantly very low, up to 50 or less cfu.
This is a result of using a minimal starting amount of circular
template vector. It is possible to reduce the background by Dpn1
digestion, but based on the low occurrence and the high positive
clone counts, this is not necessary. IFPC is suitable for a variety of
vectors. Until now, inserts between 100 bp up to 3.5 kb have been
successfully cloned into the vectors pBAD, pBAD/Thio, pET-151,
pCR2.1 (all Invitrogen), pMK90 [19], pSex81 [20] or pWPI
(Addgene plasmid 12254) to insert genes such as gfp, produce gene
fusions, swap domains or exchange antibiotic resistances. Other
vector origins than pUC or pBR322 were not tested until now, but
the vector origin should not play a role for successful cloning if it is
amplifiable by PCR.
IFPC can be carried out directly with bacteria containing the
template vector and insert from a diluted PCR, avoiding any DNA
cleanup or digestion step during the whole procedure, thus with
only minimal experimental handling. In conclusion, IFPC is a
robust and user friendly method for the directional and seamless
cloning in E. coli.
Materials and Methods
IFPC working protocol
To achieve most colonies with lowest background, the gel-eluted
insert was used containing a 59 vector complementary end with an
annealing Tm of around 58uC (59-end of primer A). The inverse
fusion PCR was prepared by mixing 500 nM primer B and C,
10 pM circular template vector and 1 nM of the gel-eluted insert,
corresponding to a molar ratio V to I of 1: 100. For 1 ml of inverse
fusion PCR mix, approximately 5 pg kb21 circular template
vector and 500 pg kb21 insert DNA was used. The inverse fusion
PCR was run by using Phusion DNA-polymerase (0.02 units ml21)
under the following conditions: 98uC for 3 min, 25 cycles of 98uC
– 20 s, 58uC – 30 s, 72uC – 30 s kb21 and a final extension step at
72uC for 7 min. The 72uC elongation step was calculated by
adding the size of the vector and the insert, and then 2 ml of the
inverse fusion PCR was mixed with 2.5 ml Quick or Rapid 26
ligation reaction buffer and subsequently 0.5 ml T4-DNA ligase
was added and incubated for 15 min at RT prior to transforma-
tion into competent E. coli cells. If non phosphorylated primers
were used for the inverse fusion PCR, the amount of inverse fusion
PCR was reduced and filled up to 2 ml with H2O. 2.5 ml Quick or
Rapid 26 ligation reaction buffer, 5 units of T4-polynucleotid
kinase and 0.5 ml T4-DNA ligase were added into the ligation mix
and incubated for 30 min at RT prior transformation.
Troubleshooting: once problems concerning buffers, enzymes
or competent cells were eliminated, two additional problems
occurred: (i) unspecific primer binding was eliminated by designing
new primers; (ii) poor amplification during the inverse fusion PCR
was overcome by the addition of cycles (e.g. for vectors containing
LacZ sequences). In some cases PCR optimization by adding GC-
buffer (FinnZymes/NEB), DMSO or OneTaq High GC Enhancer
(NEB) was necessary. Even if the inverse fusion PCR worked
perfectly, only a very small amount of product was amplified,
which was almost not visible on an agarose gel: the absence of a
visible product was not indicative for the failure of the inverse
fusion PCR reaction.
Setup and evaluation of IFPC
To change the ampicillin resistance of the vector pBAD
(Invitrogen) to a kanamycin resistance, two PCRs and one ligation
were performed. For all PCRs, the high-fidelity Phusion DNA
Polymerase (0.02 units ml21), HF-buffer (both Finnzymes) and
500 nM primers (desalted, Sigma) were used. All primer sequences
are listed in Table 2. To prepare the insert, the coding sequence
for kanamycin was amplified in a first PCR employing primer A1
and primer B1, using 1 ng of the vector pCR2.1 (Invitrogen) as
template. The vector-homologous part of primer A1 had a
calculated annealing Tm of around 58uC. After an initial
denaturation step at 98uC for 3 min, followed by 25 cycles of
98uC – 15 s, 58uC – 20 s and 72uC – 30 s, a final extension step
(7 min) at 72uC was performed. Depending on which approach
was used, the resulting PCR product was (i) diluted in H2O, (ii)
column cleaned or (iii) gel-eluted using the high pure PCR product
purification kit (Roche).
Subsequently, a second PCR, the inverse fusion PCR, was
performed in order to fuse the kanamycin sequence to the
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template vector pBAD (Invitrogen). To identify the best
conditions, different amounts (1 pg to 50 ng) of circular pBAD
and the kanamycin insert as gel-eluted from the first PCR (molar
ratio from 1: 0.1 to 1: 1,000) were mixed with a 59-phosphorylated
vector primer C1 and the insert primer B1, buffer and polymerase
as above in a total volume of 20 ml. The PCR was then performed
with the following profile: 98uC for 3 min, followed by 25 cycles of
98uC – 20 s, 65uC – 1 s, slowly decreasing at 0.1uC s21 to 58uC,
58uC – 30 s, 72uC - 3 min and a final step at 72uC for 10 min. For
some settings only one short annealing step (30 s at 58uC) or a
non-phosphorylated primer C2 and a phosphorylated primer B2
were used.
For the ligations, 2 ml of the resulting fusion PCRs were mixed
with 2.5 ml 26Quick ligation buffer and 0.5 ml Quick ligase (both
NEB) to prepare 5 ml ligation reactions. Alternatively, the rapid
ligation system (Promega) was used. The ligation reactions were
carried out at room temperature for 15 min, or for 30 min, in the
cases where 5 units of T4-polynucleotid kinase (NEB, M0236S)
were added to simultaneously phosphorylate the 59-ends of the
inverse fusion products. Finally, the whole reaction was used to
transform 50 ml chemically competent E. coli Top10 cells
(8.56108 cfu mg21 pUC19) prepared and handled according to
the CCMB80 protocol (http://openwetware.org/wiki/
TOP10_chemically_competent_cells). To check the insertion of
the kanamycin resistance gene, different amounts (1 to 100 ml) of
the transformations were plated on LB-Agar containing 50 mg
ml21 kanamycin or 100 mg ml21 ampicillin, thus to identify the
background of residual pBAD vector.
Error frequency of IFPC
Since the described setup selected only functional active
kanamycin resistant colonies, an additional experiment was
performed to identify the percentage of failed fusions. Therefore,
a spectinomycin/streptomycin resistance gene (aadA, Genbank
acc. No. M60473.1) derived from genomic DNA of E. coli rl0282
was fused in frame into the kanamycin resistance gene of the
vector pCR2.1 (Invitrogen) by simultaneously deleting the
kanamycin sequence. The heterologuous primer A3 was designed
to bind downstream of the start ATG of kanamycin, leading to a
spectinomycin sequence containing 24 kanamycin derived bases at its
59-end. This setup should allow the identification of non functional
fusions appearing as a result of miss-matches during insert-vector
fusion. Primer B3 was chosen to anneal at the 39-terminus of the
kanamycin sequence. With the same settings as described above
for the first insert PCR, aadA was amplified with the primers A3
and B3, followed by a column purification of the PCR product.
For the inverse fusion PCR phosphorylated primer C3, 400 pg
ml21 spectinomycin insert and 20 pg ml21 pCR2.1 were used, and
PCR was performed under the same conditions as described
above, except for a 30 s annealing step at 58uC. The transformed
E. coli were seeded on ampicillin plates allowing growth of bacteria
containing the non-fused vector (ampR, kanR), the functional
fusions (ampR, specR) and the non-functional fusions (ampR,
specS). 192 randomly picked colonies were seeded into wells of 96-
well plates containing LB- media with ampicillin (100 mg ml21),
kanamycin (50 mg ml21) or spectinomycin (50 mg ml21). 96 of the
functional fusion colonies were analyzed by PCR using the primers
k-dw and a-up flanking the spectinomycin insertion site in a
distance of 116 or 162 bases. The non-functional fusions, growing
in the presence of ampicillin but not kanamycin and spectinomy-
cin, were sequenced with the primers k-dw and a-up to identify the
reason of fusion failure. In addition, 10 colonies containing the
functional fusion were sequenced to confirm the presence of the
inserted spectinomycin sequence and its 59- and 39- insertion
boundaries.
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